华熙生物谈投资圣诺医药布局创新药:前沿技术成果将应用至医美和皮肤科学板块

财经网
Sep 26, 2025

9月26日,华熙生物举办2025半年度业绩说明会。会上有投资者询问公司战略投资圣诺医药布局创新药的合理性。管理层回应,本次投资是华熙生物在生物医药领域的重要布局。华熙生物的主要业务集中在原料、医药医美和皮肤科学三大板块,此次通过投资圣诺医药,不仅可以在战略层面与小核酸创新药这一前沿技术的赛道实现绑定,更能在业务层面形成多维度协同。管理层认为,华熙作为全球领先的生物活性物原料供应商,在透明质酸和麦角...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10